- Vinorelbin a cisplatina v neoadjuventní chemoterapii plicního karcinomu2001 | Lékařská fakulta v Hradci Králové
- Randomized phase III trial comparing bexarotene (L106949)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I2008 | 3. lékařská fakulta
- A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)2012 | 3. lékařská fakulta
- Long-term results of two different neoadjuvant vinorelbine and cisplatin regiments in stage III non-small cell lung cancerPublikace bez příslušnosti k fakultě
- Comparison of vinorelbine containing dublet versus triplet schedule ( vinorelbine cisplatin versus vinorelbine-ifosfamide cisplatin)2001 | Lékařská fakulta v Plzni
- Gemcitabin, cisplatin (GP) versus vinorelbine, ifosfamide, cisplatin (NIP) in locally advanced non-small cell lung cancer (NSCLC)2001 | Ústřední knihovna, Lékařská fakulta v Plzni
- Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer. A randomized phase II study +1Publikace bez příslušnosti k fakultě
- Evaluation of radiation pneumotoxicity in patients with locally advancet non-small cell lung cancer (NSCLC) treated by concurrent versus sequential radiochomotherapy in with vinorelbine plus cisplatin ( V-P)Publikace bez příslušnosti k fakultě
- Concurrent Versus Sequential Radiochemotherapy With Vinorelbine Plus Cisplatin (V-P) In Locally Advanced Non-small Cell Lung cancer. A randomized phase II study - long-term follow-up data2003 | 1. lékařská fakulta
- Pulmonary toxicity and lung functions in patients with locally advanced non-small cell lung cancer (NSCLC) treated by concurrent versus sequential radiochemotherapy with vinorelbin plus cisplatin (V-P)Publikace bez příslušnosti k fakultě
- Concurrent Versus Sequential Radiochemotherapy With Vinorelbine Plus Cisplatin (V-P) In Locally Advanced Non-small Cell Lung cancer. A randomized phase II study - long-term follow-up data2003 | Fakulta tělesné výchovy a sportu
- Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer2009 | 3. lékařská fakulta
- Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer2008 | 3. lékařská fakulta
- Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up2017 | Publikace bez příslušnosti k fakultě